XTRA:EVTLife Sciences
Evotec (XTRA:EVT) Valuation Check After Toulouse Plant Sale and Shift to Asset‑Light Model
Evotec (XTRA:EVT) just closed the sale of its Just, Evotec Biologics Toulouse plant to Sandoz and handed over an indefinite license to its continuous manufacturing tech, signaling a deliberate pivot toward a more asset-light model.
See our latest analysis for Evotec.
The strategic sale comes after a tough stretch, with a year to date share price return of negative 37.21 percent and a one year total shareholder return of negative 39.5 percent. This suggests sentiment is still rebuilding, even...